NCT06209008View on ClinicalTrials.gov

Submucosal Intravesical Injection of Platelet-rich Plasma in the Treatment of Painful Bladder Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

April 1, 2023

Study Completion Date

December 1, 2023

Conditions
Painful Bladder Syndrome (PBS)Interstitial Cystitis
Interventions
DRUG

Intravesical injection of Platlet Rich Plasma (PRP)

Patients will receive 20 submucosal injections of PRP solution, each injection site receives 0.5 mL PRP. The injection needle will be inserted about 1 mm into the at the posterior and lateral walls of the bladder, using a 23 gauge needle and 22 F rigid cystoscope.

Trial Locations (1)

1181

Demerdash hospital, Faculty of medicine, Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06209008 - Submucosal Intravesical Injection of Platelet-rich Plasma in the Treatment of Painful Bladder Syndrome | Biotech Hunter | Biotech Hunter